Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Minivita DHA
- Development stage
- Unknown
- Lead developer
- PT Tunggal Idaman Abadi
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
`Minivita DHA` (also known as `Minivita + DHA`) is an oral multivitamin syrup developed and marketed by Tunggal Idaman Abdi. It is formulated to support the nutritional and multivitamin requirements of children during growth phases and during recovery from illness. The supplement contains a combination of essential fatty acids, vitamins, and amino acids, including arachidonic acid (AA), docosahexaenoic acid (DHA), vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin C, vitamin D3, nicotinamide, calcium pantothenate, and L-lysine hydrochloride. These ingredients work synergistically to support brain development, cognitive function, immune health, and overall physical growth in pediatric populations.
- Brand names
- Minivita + DHAMinivita DHA
02
Targets
RAR (Retinoic acid receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Minivita DHA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Minivita DHA.